Navigation Links
Eli Lilly and Company Named a Top Global Company for Leaders
Date:12/1/2011

INDIANAPOLIS, Dec. 1, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) has been named one of the top 25 global companies for leaders by Aon Hewitt in partnership with FORTUNE and the RBL Group. Lilly ranked 16th on the Global 25 list and 12th on the North American list.

The survey is one of the most comprehensive studies of talent management and leadership practices around the globe.

Companies first complete an extensive survey, and senior executives from 182 global finalists are interviewed. An expert panel of independent judges then selects and ranks winners based on criteria, including strength of leadership practices and culture, examples of leader development on a global scale, impact of leadership in communities in which they operate, business performance and company reputation. 

"Lilly is honored to be named one of the top companies in the world for cultivating leadership talent," said Steve Fry, senior vice president of human resources and diversity.

"Our long-term responsibility is to ensure Lilly has a talent pipeline for the future. Just as we work diligently to advance our drug pipeline, we need to do the same for our people pipeline. We are constantly working to identify and develop leaders," Fry said.

Lilly has emphasized the importance of having a strong succession management process for many years. As a result, the vast majority of Lilly's senior management team has been developed within the company. Many began their careers at Lilly affiliates around the world.  Presently more than 50 percent of the company's top leadership is from outside the United States.

In addition to its global succession management process, Lilly's offers a variety of programs and activities, including experiential learning programs, on-line trainings, and teaching opportunities, designed to build leadership skills.

To learn more about the award or to download a copy of this study, please visit
http://aon.mediaroom.com/index.php?s=43&item=2465.

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.  C-LLY


(Logo: http://photos.prnewswire.com/prnh/20031219/LLYLOGO)

 


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Lilly Provides Additional Funding to Infectious Disease Research Institute to Identify New Tuberculosis Therapies
2. Lilly CEO Lechleiter Outlines Opportunities for Improved Health and Economic Growth in Asia-Pacific Region
3. Lilly and Amylin Mutually Agree to End Diabetes Alliance and Transition Exenatide Responsibility to Amylin
4. Lilly CEO Says Appropriate Assessment of Both Benefits and Risks Critical in Regulatory Process
5. Lilly Foundation Commits US $30 Million to The Lilly MDR-TB Partnership
6. Lilly Provides Update on 2011 Financial Guidance Due to Xigris Withdrawal
7. Prasco® Selected as Eli Lilly and Companys Authorized Generics Partner
8. Lilly Reports Third-Quarter 2011 Results
9. Lilly Declares Fourth-Quarter 2011 Dividend
10. Lilly Announces Changes in Senior Management
11. Lilly Confirms Date and Conference Call for Third-Quarter 2011 Financial Results Announcement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... Feb. 4, 2016  SciClone Pharmaceuticals, Inc. (NASDAQ: ... has entered into a settlement agreement with the ... resolving the SEC,s investigation into possible violations of ... terms of the settlement agreement, SciClone has agreed ... disgorgement, pre-judgment interest and a penalty.  This payment ...
(Date:2/4/2016)... -- Frontier Pharma: Chronic Obstructive Pulmonary Disease (COPD) ... Chronic Obstructive Pulmonary Disease (COPD) is a ... airways and lungs. Persistent breathing difficulties and repeated ... of the leading causes of morbidity and the ... is linked to cumulative exposure to risk factors, ...
(Date:2/4/2016)... ALBANY, N.Y. , Feb. 4, 2016  AMRI (NASDAQ: ... Vice President of Pfizer Inc. and President of Pfizer Global ... effective as of February 4, 2016. In addition, the Company ... member of the audit committee since 2010, has retired from ... time and attention to his other business ventures.  ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... February 05, 2016 , ... Today, the Whole-Food Warrior TV show, ... much-anticipated feature with author Jahnavi Foster, specialist in healthy vegetarian cuisine, will stream on ... week, on his weekly Whole-Food Warrior TV show, Frank Davis highlights Whole-Food Warriors - ...
(Date:2/5/2016)... New York, New York (PRWEB) , ... February 05, 2016 , ... ... your life? The answer may be at the tips of your toes. Foot massage, ... benefits as well as pure comfort and relaxation. The American Board of Multiple ...
(Date:2/5/2016)... ... February 05, 2016 , ... In the fourth quarter of ... at the La Valencia Hotel in San Diego, California to discuss changes in ... year’s most outstanding franchise, walking away with the coveted David Wright Award of ...
(Date:2/5/2016)... ... 2016 , ... Pivot Point Consulting, a leading national Healthcare ... Services for HIT Implementation Support & Staffing report with an outstanding score of ... healthcare executives, managers and clinicians representing over 4,500 hospitals and 2,500 clinics. , ...
(Date:2/5/2016)... ... , ... Colorize is a web theme package created exclusively for ... Colorize's dynamic moving camera. Colorize is perfect for personal and web related videos and ... 1 to 5 focus points per scene, stage floor scene presets that are great ...
Breaking Medicine News(10 mins):